Biosens Labs is a biotechnology company focused on the development of novel Point-Of-Care Testing (POCT) detection methods and technologies. We are working on electrochemical and optical methods for rapid detection of genetic material, antigens, and biomarkers in biological fluids. Our POCT solutions are dedicated to infectious diseases, but also lung diseases and cancer. Biosens Labs also offers commercial partnership options in early phase biological drug discovery and development, including drug screening, biophysical molecule characterization, in vitro and in vivo drug testing in cells and animal mouse models.
